A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: A retrospective study

ObjectiveThe prognostic effect of delayed treatment on stage IA1 non-small cell lung cancer (NSCLC) patients is still unclear. This study aimed to explore the association between the waiting time before treatment and the prognosis in stage IA1 NSCLC patients.MethodsEligible patients diagnosed with p...

Full description

Bibliographic Details
Main Authors: Bin Liu, Jia-Yi Qian, Lei-Lei Wu, Jun-Quan Zeng, Shu-Quan Xu, Jin-Hua Yuan, Yong-Liang Zheng, Dong Xie, Xiaolu Chen, Hai-Hong Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Surgery
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2022.987075/full
_version_ 1797998908622766080
author Bin Liu
Jia-Yi Qian
Lei-Lei Wu
Jun-Quan Zeng
Shu-Quan Xu
Jin-Hua Yuan
Yong-Liang Zheng
Dong Xie
Xiaolu Chen
Hai-Hong Yu
Hai-Hong Yu
author_facet Bin Liu
Jia-Yi Qian
Lei-Lei Wu
Jun-Quan Zeng
Shu-Quan Xu
Jin-Hua Yuan
Yong-Liang Zheng
Dong Xie
Xiaolu Chen
Hai-Hong Yu
Hai-Hong Yu
author_sort Bin Liu
collection DOAJ
description ObjectiveThe prognostic effect of delayed treatment on stage IA1 non-small cell lung cancer (NSCLC) patients is still unclear. This study aimed to explore the association between the waiting time before treatment and the prognosis in stage IA1 NSCLC patients.MethodsEligible patients diagnosed with pathological stage IA1 NSCLC were included in this study. The clinical endpoints were overall survival (OS) and cancer-specific survival (CSS). The Kaplan-Meier method, the Log-rank test, univariable, and multivariable Cox regression analyses were used in this study. Propensity score matching was used to reduce the bias of data distribution.ResultsThere were eligible 957 patients in the study. The length of waiting time before treatment stratified the survival in patients [<3 months vs. ≥3-months, unadjusted hazard ratio (HR) = 0.481, P = 0.007; <2 months vs. ≥2-months, unadjusted HR = 0.564, P = 0.006; <1 month vs. ≥1-month, unadjusted HR = 0.537, P = 0.001]. The 5-year CSS rates were 95.0% and 77.0% in patients of waiting time within 3 months and over 3 months, respectively. After adjusting for other confounders, the waiting time was identified as an independent prognostic factor.ConclusionsA long waiting time before treatment may decrease the survival of stage IA1 NSCLC patients. We propose that the waiting time for those patients preferably is less than one month and should not exceed two months.
first_indexed 2024-04-11T10:56:12Z
format Article
id doaj.art-3081414ac5a84d1e8f531dd3e2054059
institution Directory Open Access Journal
issn 2296-875X
language English
last_indexed 2024-04-11T10:56:12Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Surgery
spelling doaj.art-3081414ac5a84d1e8f531dd3e20540592022-12-22T04:28:46ZengFrontiers Media S.A.Frontiers in Surgery2296-875X2022-09-01910.3389/fsurg.2022.987075987075A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: A retrospective studyBin Liu0Jia-Yi Qian1Lei-Lei Wu2Jun-Quan Zeng3Shu-Quan Xu4Jin-Hua Yuan5Yong-Liang Zheng6Dong Xie7Xiaolu Chen8Hai-Hong Yu9Hai-Hong Yu10Department of Oncology, The Affiliated Hospital of Jinggangshan University, Ji’an, ChinaDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Oncology, The Affiliated Hospital of Jinggangshan University, Ji’an, ChinaSchool of Medicine, Tongji University, Shanghai, ChinaDepartment of Oncology, The Affiliated Hospital of Jinggangshan University, Ji’an, ChinaDepartment of Oncology, The Affiliated Hospital of Jinggangshan University, Ji’an, ChinaDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Respiratory and Critical Care, The Affiliated People’s Hospital of Ningbo University, Ningbo, ChinaSchool of Medicine, Tongji University, Shanghai, ChinaSchool of Medicine, Jinggangshan University, Ji'an, ChinaObjectiveThe prognostic effect of delayed treatment on stage IA1 non-small cell lung cancer (NSCLC) patients is still unclear. This study aimed to explore the association between the waiting time before treatment and the prognosis in stage IA1 NSCLC patients.MethodsEligible patients diagnosed with pathological stage IA1 NSCLC were included in this study. The clinical endpoints were overall survival (OS) and cancer-specific survival (CSS). The Kaplan-Meier method, the Log-rank test, univariable, and multivariable Cox regression analyses were used in this study. Propensity score matching was used to reduce the bias of data distribution.ResultsThere were eligible 957 patients in the study. The length of waiting time before treatment stratified the survival in patients [<3 months vs. ≥3-months, unadjusted hazard ratio (HR) = 0.481, P = 0.007; <2 months vs. ≥2-months, unadjusted HR = 0.564, P = 0.006; <1 month vs. ≥1-month, unadjusted HR = 0.537, P = 0.001]. The 5-year CSS rates were 95.0% and 77.0% in patients of waiting time within 3 months and over 3 months, respectively. After adjusting for other confounders, the waiting time was identified as an independent prognostic factor.ConclusionsA long waiting time before treatment may decrease the survival of stage IA1 NSCLC patients. We propose that the waiting time for those patients preferably is less than one month and should not exceed two months.https://www.frontiersin.org/articles/10.3389/fsurg.2022.987075/fullnon-small cell lung cancerstage IA1delayed treatmentprognosissurgery
spellingShingle Bin Liu
Jia-Yi Qian
Lei-Lei Wu
Jun-Quan Zeng
Shu-Quan Xu
Jin-Hua Yuan
Yong-Liang Zheng
Dong Xie
Xiaolu Chen
Hai-Hong Yu
Hai-Hong Yu
A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: A retrospective study
Frontiers in Surgery
non-small cell lung cancer
stage IA1
delayed treatment
prognosis
surgery
title A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: A retrospective study
title_full A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: A retrospective study
title_fullStr A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: A retrospective study
title_full_unstemmed A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: A retrospective study
title_short A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: A retrospective study
title_sort long waiting time from diagnosis to treatment decreases the survival of non small cell lung cancer patients with stage ia1 a retrospective study
topic non-small cell lung cancer
stage IA1
delayed treatment
prognosis
surgery
url https://www.frontiersin.org/articles/10.3389/fsurg.2022.987075/full
work_keys_str_mv AT binliu alongwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT jiayiqian alongwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT leileiwu alongwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT junquanzeng alongwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT shuquanxu alongwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT jinhuayuan alongwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT yongliangzheng alongwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT dongxie alongwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT xiaoluchen alongwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT haihongyu alongwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT haihongyu alongwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT binliu longwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT jiayiqian longwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT leileiwu longwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT junquanzeng longwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT shuquanxu longwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT jinhuayuan longwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT yongliangzheng longwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT dongxie longwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT xiaoluchen longwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT haihongyu longwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy
AT haihongyu longwaitingtimefromdiagnosistotreatmentdecreasesthesurvivalofnonsmallcelllungcancerpatientswithstageia1aretrospectivestudy